{
"id":"mk19_bb_on_s21",
"subspecialtyId":"on",
"title":"Febrile Neutropenia",
"jsonContent":{
"type":"section",
"id":"mk19_bb_on_s21",
"title":{
"__html":"Febrile Neutropenia"
},
"titleNode":{
"type":"section-title",
"hlId":"9b2479",
"children":[
"Febrile Neutropenia"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_on_s21_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"b14c79",
"children":[
"Fever is defined as a single oral temperature >38.3 °C (101.0 °F) or a temperature >38.0 °C (100.4 °F) sustained over a 1-hour period. The first step in managing febrile neutropenia is identifying high- and low-risk patients."
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"e6cae9",
"children":[
"High risk is defined as neutropenia for ≥7 days with an absolute neutrophil count ≤100/μL and/or significant comorbidities (e.g., hypotension, pneumonia, abdominal pain, neurologic changes)."
]
},
" ",
{
"type":"list-item",
"hlId":"7fb922",
"children":[
"Low risk is defined as anticipated neutropenia for <7 days and no or few comorbidities."
]
},
" "
]
},
{
"type":"p",
"hlId":"adf1ab",
"children":[
"Obtain at least two sets of blood cultures, and culture any obvious source of infection. Signs and symptoms guide imaging; no routine imaging tests exist."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s21_2",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"6de262",
"children":[
"Management of high-risk febrile neutropenia:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"e3f420",
"children":[
"Admit all high-risk patients to the hospital for empiric IV antibiotics."
]
},
" ",
{
"type":"list-item",
"hlId":"88fcc3",
"children":[
"Begin empiric monotherapy with an antipseudomonal β-lactam (e.g., cefepime), a carbapenem (e.g., imipenem-cilastatin), or piperacillin-tazobactam."
]
},
" "
]
},
{
"type":"p",
"hlId":"057f7c",
"children":[
"Management of low-risk febrile neutropenia:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"163d23",
"children":[
"Low-risk patients may be candidates for outpatient empiric antibiotic therapy."
]
},
" ",
{
"type":"list-item",
"hlId":"2ba9f4",
"children":[
"Begin oral or IV antibiotics in the clinic or hospital setting, with transition to the outpatient setting if the patient remains stable during a 4- to 24-hour period of observation."
]
},
" "
]
},
{
"type":"p",
"hlId":"3c1f2d",
"children":[
"Modify the initial therapy for patients at high risk for antibiotic-resistant organisms (e.g., unstable patient, early suggestive blood culture results):"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"2b3887",
"children":[
"Add vancomycin, linezolid, or daptomycin for suspected ",
{
"type":"abbreviation",
"title":"methicillin-resistant Staphylococcus aureus",
"children":[
"MRSA"
]
},
" infection."
]
},
" ",
{
"type":"list-item",
"hlId":"073301",
"children":[
"Add linezolid or daptomycin for suspected vancomycin-resistant enterococci."
]
},
" ",
{
"type":"list-item",
"hlId":"9923f4",
"children":[
"Begin empiric antifungal therapy for persistent fever despite 4 to 7 days of empiric antibiotics and anticipated neutropenia for ≥7 days."
]
},
" "
]
},
{
"type":"p",
"hlId":"73b3f0",
"children":[
"Continue antibiotics until the absolute neutrophil count is ≥500/μL or longer, depending on clinical circumstances."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"7c9478",
"children":[
"Vancomycin is not recommended as standard initial therapy for febrile neutropenia."
]
},
" ",
{
"type":"list-item",
"hlId":"e03399",
"children":[
"Do not use myeloid colony-stimulating factors for treatment of febrile neutropenia."
]
},
" ",
{
"type":"list-item",
"hlId":"e6a957",
"children":[
"Antiviral treatment is indicated only for clinical evidence of active viral infection."
]
},
" ",
{
"type":"list-item",
"hlId":"0ce92e",
"children":[
"Typhlitis (necrotizing enterocolitis) should be suspected in patients with neutropenia and even minimal ",
{
"type":"abbreviation",
"title":"right lower quadrant",
"children":[
"RLQ"
]
},
" abdominal pain; obtain an abdominal CT scan."
]
},
" ",
{
"type":"list-item",
"hlId":"802240",
"children":[
" ",
{
"type":"alert",
"children":[
"Diagnose angioinvasive aspergillosis in neutropenic patients with leukemia receiving prolonged antibiotic therapy."
]
},
" "
]
},
" "
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_on_f05"
],
"forceOpen":true
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s21_3",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"dcdb42",
"class":"test",
"children":[
"A 73-year-old man with ",
{
"type":"abbreviation",
"title":"acute myeloid leukemia",
"children":[
"AML"
]
},
" develops febrile neutropenia on the eighth day of chemotherapy. Ceftazidime is begun, but after 5 days of therapy he remains febrile and neutropenic. Blood cultures are negative, and he has no localizing signs of infection."
]
},
{
"type":"p",
"hlId":"03c861",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For management, add amphotericin B or itraconazole."
]
}
]
}
]
},
"tablesContent":{
}
}